← The Wire
RNTXNasdaq
Rein Therapeutics, Inc.
Pharmaceutical Preparations · CIK 1420565
Developing novel therapies for orphan pulmonary and fibrosis indications with limited effective treatments
$82M
Market cap
$1.04
Last close
+7.1%
1D
+15.1%
5D
869K
Volume
Price · last 39 sessions+2.0%
May 4L $0.86 · H $1.22Jun 29
184
Total filings
Jun 8, 2026
Last filing
12/31
Fiscal year end
DEFA14ADEFA14AJun 8, 2026DEF 14ADEF 14AJun 8, 202610-Q10-QMay 15, 20268-KMaterial Agreement · Company UpdateMay 4, 2026424B5424B5May 4, 2026S-1S-1Apr 28, 202610-K/A10-K/AApr 27, 202610-K10-KMar 26, 20268-KMaterial Agreement · New Debt / ObligationMar 2, 20268-KExecutive ChangeFeb 19, 20268-KMaterial Agreement · New Debt / ObligationJan 16, 20268-KAgreement TerminatedDec 11, 202510-Q10-QNov 14, 20258-KCompany UpdateNov 3, 20258-KMaterial Agreement · New Debt / ObligationOct 24, 20258-KCompany UpdateOct 9, 20258-KCompany UpdateSep 22, 20258-KMaterial Agreement · New Debt / ObligationSep 9, 2025S-1S-1Sep 3, 20258-KCompany UpdateAug 19, 202510-Q10-QAug 14, 20258-KMaterial Agreement · New Debt / ObligationJul 30, 2025424B5424B5Jul 30, 2025424B5424B5Jul 30, 20258-KShareholder VoteJul 23, 2025DEFA14ADEFA14AJul 11, 20258-KBylaw Amendment · Company UpdateJul 11, 2025DEFA14ADEFA14AJun 24, 20258-KCompany UpdateJun 24, 20258-KCompany UpdateJun 12, 20258-KResults of OperationsMay 15, 202510-Q10-QMay 15, 2025424B5424B5May 15, 2025DEFA14ADEFA14AMay 12, 2025DEF 14ADEF 14AMay 12, 202510-K/A10-K/AApr 30, 20258-KMaterial Agreement · Equity IssuanceApr 22, 20258-KAuditor ChangeApr 17, 202510-K10-KApr 7, 20258-KBylaw Amendment · Company UpdateJan 10, 20258-KResults of OperationsNov 14, 202410-Q10-QNov 14, 20248-KShareholder VoteAug 21, 20248-KResults of OperationsAug 14, 202410-Q10-QAug 14, 20248-KMaterial Agreement · Company UpdateJul 26, 2024424B5424B5Jul 26, 2024424B5424B5Jul 26, 2024DEFA14ADEFA14AJul 9, 2024DEF 14ADEF 14AJul 9, 20248-KCompany UpdateJun 5, 20248-KExecutive ChangeMay 16, 20248-KResults of OperationsMay 15, 202410-Q10-QMay 15, 20248-KMaterial Agreement · Company UpdateMay 1, 2024424B5424B5May 1, 20248-KResults of Operations · Company UpdateMay 1, 202410-K/A10-K/AApr 29, 20248-KResults of OperationsApr 15, 202410-K10-KApr 15, 20248-KExecutive ChangeMar 29, 20248-KExecutive Change · Reg FD DisclosureMar 15, 2024SC 13GSC 13GMar 5, 20248-KExecutive Change · Company UpdateMar 1, 20248-KExecutive Change · Bylaw AmendmentFeb 29, 20248-KExecutive ChangeFeb 13, 2024DEFA14ADEFA14AJan 31, 2024DEF 14ADEF 14AJan 29, 20248-KCompany UpdateJan 29, 20248-KCompany UpdateJan 25, 20248-K/ACompany UpdateJan 11, 20248-KDelisting Notice · Auditor ChangeJan 10, 2024SC 13GSC 13GNov 13, 20238-KAuditor Change · Executive ChangeOct 31, 202310-Q10-QOct 13, 202310-Q10-QAug 11, 202310-Q10-QMay 8, 202310-K/A10-K/AApr 28, 202310-K10-KMar 20, 20238-KExit / Disposal Costs · Company UpdateFeb 23, 2023
Insider Activity
◆ Cluster Buy · 2 insidersIn the 90 days to Nov 14, 2025: 2 insiders bought $551K.
| Date | Insider | Action | Shares | Price | Value |
|---|---|---|---|---|---|
| Nov 14, 2025 | Voss Value Master Fund, LpTenPercentOwner | Buy | 104,183 | $1.22 | $127K |
| Oct 28, 2025 | Voss Value-Oriented Special Situations Fund, LpTenPercentOwner | Buy | 178,392 | $1.39 | $248K |
| Oct 27, 2025 | Voss Value-Oriented Special Situations Fund, LpTenPercentOwner | Buy | 92,642 | $1.37 | $127K |
| Oct 27, 2025 | Voss Value-Oriented Special Situations Fund, LpTenPercentOwner | Buy | 4,840 | $1.37 | $7K |
| Oct 24, 2025 | Voss Value-Oriented Special Situations Fund, LpTenPercentOwner | Buy | 30,176 | $1.39 | $42K |
Open-market buys & sells (Form 4, transaction codes P/S). Source: SEC structured insider data.
Similar companies
Comparable business profile · signals at a glance